Orange Book product · Generic (ANDA)
IMIQUIMOD
IMIQUIMOD
At a glance
Mar 06, 2012
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 06, 2012
14 yr 6 mo ago
Today
Pharmaceutical detail
Active ingredient
IMIQUIMOD
Strength
5%
Dosage form
CREAM
Route
TOPICAL
TE code
AB
Application
ANDA 201994
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of IMIQUIMOD
- 2011ZYCLARABrand (NDA)
NDA 022483 · BAUSCH
- 1997ALDARABrand (NDA)
NDA 020723 · BAUSCH
- 2021IMIQUIMODGeneric (ANDA)
ANDA 205971 · TARO
- 2014IMIQUIMODGeneric (ANDA)
ANDA 202002 · STRIDES PHARMA
- 2012IMIQUIMODGeneric (ANDA)
ANDA 091308 · APOTEX INC
- 2011IMIQUIMODGeneric (ANDA)
ANDA 200481 · COSETTE
- 2011IMIQUIMODGeneric (ANDA)
ANDA 200173 · TARO
- 2011IMIQUIMODGeneric (ANDA)
ANDA 091044 · ENCUBE
- 2010IMIQUIMODGeneric (ANDA)
ANDA 078837 · PADAGIS ISRAEL
- 2010IMIQUIMODGeneric (ANDA)
ANDA 078548 · FOUGERA PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
